Diabetes insipidus secondary to combination atypical antipsychotic and lithium use in a bipolar disorder patient: A case report

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 13, Issue 4, 2011, Pages 16-

  Rej, Soham ^a   Margolese, Howard C ^a   Low, Nancy C P ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CREATININE; GLUCOSE; LITHIUM CARBONATE; LONG ACTING DRUG; PALIPERIDONE; QUETIAPINE; RISPERIDONE; SODIUM;

ADULT; ADVERSE OUTCOME; BIPOLAR DISORDER; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DIABETES INSIPIDUS; DISEASE CLASSIFICATION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG USE; DRUG WITHDRAWAL; EVENING DOSAGE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSOMNIA; KIDNEY FUNCTION TEST; LETTER; NOCTURIA; POLYDIPSIA; SODIUM BLOOD LEVEL; TREATMENT DURATION; URINE OSMOLALITY;

EID: 80053088254     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.11l01138     Document Type: Letter

References (2)

1. Boton R, Gaviria M, Batlle DC. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis. 1987;10(5):329-345. PubMed
2. Movig KL, Baumgarten R, Leufkens HG, et al. Risk factors for the development of lithium-induced polyuria. Br J Psychiatry. 2003;182(4):319-323. PubMed doi:10.1192/bjp.182.4.319